Oral Janus kinase inhibitors for treating hospitalized patients with COVID-19: An updated systematic review and meta-analysis of randomized controlled trials

OBJECTIVES: This study investigated the clinical efficacy and safety of oral Janus kinase inhibitors (JAKis) in the treatment of hospitalized patients with COVID-19. METHODS: The PubMed, Embase, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov databases were searched for releva...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Hung-Jen, Weng, Teng-Song, Chen, Yu-Hung, Chao, Chien-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381941/
https://www.ncbi.nlm.nih.gov/pubmed/36031531
http://dx.doi.org/10.1016/j.jmii.2022.08.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381941/
https://www.ncbi.nlm.nih.gov/pubmed/36031531
http://dx.doi.org/10.1016/j.jmii.2022.08.005

Ejemplares similares